Hecht Beth — SEC insider filings

SEC reporting owner CIK 1652410. 32 insider filings on record with FilingPulse; latest filed 2026-11-04.

Transaction summary — filings shown

Covers all 32 filings on record, filed 2020-08-17 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Xeris Biopharma Holdings, Inc. (XERS)See Remarks21—15 legs · 265,000 sh · $1,935,44228
Iterum Therapeutics plc (ITRM)Director6——9
XERIS PHARMACEUTICALS INC (XERS)See Remarks3——9
Neos Therapeutics, Inc. (NEOS)Director1——6
AYTU BIOPHARMA, INC (AYTU)Director1——1

Insider filings — Hecht Beth

FiledFormIssuerReported transactionsSource
2026-11-044Xeris Biopharma Holdings, Inc. (XERS)Sale (S): 25,000 @ $10.23EDGAR
2026-10-024Xeris Biopharma Holdings, Inc. (XERS)Sale (S): 16,666 @ $9.41EDGAR
2026-09-014Xeris Biopharma Holdings, Inc. (XERS)Sale (S): 16,666 @ $8.49EDGAR
2026-08-044Xeris Biopharma Holdings, Inc. (XERS)Sale (S): 16,666 @ $8.01EDGAR
2026-07-024Xeris Biopharma Holdings, Inc. (XERS)Sale (S): 16,666 @ $8.03EDGAR
2026-06-024Xeris Biopharma Holdings, Inc. (XERS)Sale (S): 16,667 @ $6.06EDGAR
2026-05-014Xeris Biopharma Holdings, Inc. (XERS)Sale (S): 16,667 @ $6.23EDGAR
2026-04-034Xeris Biopharma Holdings, Inc. (XERS)Sale (S): 16,667 @ $5.99EDGAR
2026-03-044Xeris Biopharma Holdings, Inc. (XERS)Sale (S): 16,567 @ $6.24 · Sale (S): 100 @ $7.06EDGAR
2026-02-024Xeris Biopharma Holdings, Inc. (XERS)Grant/award (A): 121,293 @ $0 · Tax withholding (F): 98,375 @ $7.36 · Tax withholding (F): 46,914 @ $7.36 · Tax withholding (F): 24,266 @ $7.36 · Sale (S): 16,667 @ $7.45 · Grant/award (A): 162,162 (derivative) @ $0EDGAR
2026-01-054Xeris Biopharma Holdings, Inc. (XERS)Sale (S): 16,667 @ $7.43EDGAR
2025-12-024Xeris Biopharma Holdings, Inc. (XERS)Sale (S): 16,667 @ $7.01EDGAR
2025-11-134Xeris Biopharma Holdings, Inc. (XERS)Sale (S): 16,667 @ $7.40EDGAR
2025-03-214Xeris Biopharma Holdings, Inc. (XERS)Sale (S): 40,000 @ $5.43EDGAR
2025-02-034Xeris Biopharma Holdings, Inc. (XERS)Tax withholding (F): 45,909 @ $3.56 · Tax withholding (F): 98,375 @ $3.56 · Grant/award (A): 185,000 @ $0 · Grant/award (A): 300,000 (derivative) @ $0EDGAR
2025-01-074Xeris Biopharma Holdings, Inc. (XERS)Tax withholding (F): 32,039 @ $3.61EDGAR
2024-08-094Xeris Biopharma Holdings, Inc. (XERS)Tax withholding (F): 14,037 @ $2.11 · Tax withholding (F): 4,448 @ $2.11 · Tax withholding (F): 33,488 @ $1.12 · Tax withholding (F): 21,177 @ $1.26 · Tax withholding (F): 5,784 @ $1.24 · Tax withholding (F): 33,488 @ $2.24 · +2 moreEDGAR
2024-01-314Xeris Biopharma Holdings, Inc. (XERS)Grant/award (A): 750,000 @ $0EDGAR
2023-06-154Iterum Therapeutics plc (ITRM)Option exercise (M): 15,853 @ $0 · Option exercise (M): 15,853 (derivative) @ $0EDGAR
2023-02-014Xeris Biopharma Holdings, Inc. (XERS)Grant/award (A): 350,000 @ $0EDGAR
2022-06-244Iterum Therapeutics plc (ITRM)Option exercise (M): 36,798 @ $0 · Option exercise (M): 36,798 (derivative) @ $0EDGAR
2022-06-174Iterum Therapeutics plc (ITRM)Grant/award (A): 237,795 (derivative) @ $0.01EDGAR
2022-03-224Iterum Therapeutics plc (ITRM)Option exercise (M): 7,642 @ $0 · Option exercise (M): 7,642 (derivative) @ $0EDGAR
2022-01-054Xeris Biopharma Holdings, Inc. (XERS)Grant/award (A): 225,000 @ $0EDGAR
2021-10-054XERIS PHARMACEUTICALS INC (XERS)Disposition to issuer (D): 26,366 · Disposition to issuer (D): 180,000 · Disposition to issuer (D): 30,879 (derivative) · Disposition to issuer (D): 65,295 (derivative) · Disposition to issuer (D): 3,826 (derivative) · Disposition to issuer (D): 32,500 (derivative) · +1 moreEDGAR
2021-10-054Xeris Biopharma Holdings, Inc. (XERS)Grant/award (A): 26,366 · Grant/award (A): 180,000 · Grant/award (A): 30,879 (derivative) · Grant/award (A): 65,295 (derivative) · Grant/award (A): 3,826 (derivative) · Grant/award (A): 32,500 (derivative) · +1 moreEDGAR
2021-06-254Iterum Therapeutics plc (ITRM)Grant/award (A): 36,798 (derivative) @ $0EDGAR
2021-04-124AYTU BIOPHARMA, INC (AYTU)Grant/award (A): 6,500 @ $0EDGAR
2021-03-194Neos Therapeutics, Inc. (NEOS)Disposition to issuer (D): 23,453 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 14,777 (derivative) @ $0 · Disposition to issuer (D): 18,322 (derivative) @ $0 · Disposition to issuer (D): 22,756 (derivative) @ $0 · Disposition to issuer (D): 46,907 (derivative) @ $0EDGAR
2021-03-194Iterum Therapeutics plc (ITRM)Grant/award (A): 7,642 (derivative) @ $0EDGAR
2021-02-014XERIS PHARMACEUTICALS INC (XERS)Grant/award (A): 150,000 @ $0EDGAR
2020-08-174XERIS PHARMACEUTICALS INC (XERS)Grant/award (A): 150,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1652410 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs